CAD 0.16
(-6.06%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.01 CAD | 22.69% |
2022 | -0.01 CAD | 60.6% |
2021 | -0.03 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.00 CAD | -750.0% |
2024 Q1 | 0.00 CAD | 144.44% |
2024 Q3 | -0.00 CAD | -76.92% |
2023 Q2 | -0.00 CAD | 74.29% |
2023 Q1 | -0.00 CAD | -52.17% |
2023 Q3 | -0.00 CAD | -355.56% |
2023 FY | - CAD | 22.69% |
2023 Q4 | -0.00 CAD | 78.05% |
2022 Q2 | -0.00 CAD | 5.56% |
2022 Q1 | -0.00 CAD | 0.0% |
2022 Q3 | -0.00 CAD | 26.47% |
2022 FY | - CAD | 60.6% |
2022 Q4 | -0.00 CAD | 8.0% |
2021 Q3 | -0.03 CAD | 0.0% |
2021 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -0.45 CAD | 97.956% |
Asep Medical Holdings Inc | -0.13 CAD | 92.923% |
BetterLife Pharma Inc. | -0.03 CAD | 65.152% |
BioVaxys Technology Corp. | -0.06 CAD | 83.944% |
ChitogenX Inc. | -0.02 CAD | 56.808% |
Rapid Dose Therapeutics Corp. | -0.04 CAD | 77.561% |
Defence Therapeutics Inc. | -0.30 CAD | 96.933% |
Entheon Biomedical Corp. | -0.05 CAD | 81.89% |
Gemina Laboratories Ltd. | -0.07 CAD | 87.222% |
Glow Lifetech Corp. | -0.03 CAD | 68.056% |
Lexston Life Sciences Corp. | -0.02 CAD | 60.0% |
Doseology Sciences Inc. | -0.08 CAD | 88.457% |
MYND Life Sciences Inc. | -0.03 CAD | 71.34% |
Nova Mentis Life Science Corp. | -0.01 CAD | -10.843% |
PharmaTher Holdings Ltd. | -0.04 CAD | 73.938% |
PreveCeutical Medical Inc. | -0.00 CAD | -283.333% |
Telescope Innovations Corp. | -0.12 CAD | 92.333% |